Risk factors associated with safety of preschool peanut oral immunotherapy

BACKGROUND: An understanding of how patient characteristics such as age, baseline peanut-specific IgE, and atopic comorbidities may influence potential safety outcomes during peanut oral immunotherapy (P-OIT) could aid in shared decision making between clinicians and patient families. OBJECTIVE: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Karunakaran, Duva, Chan, Edmond S., Zhang, Qian, Bone, Jeffrey N., Carr, Stuart, Kapur, Sandeep, Rex, Gregory A., McHenry, Mary, Cameron, Scott B., Cook, Victoria E., Leo, Sara, Wong, Tiffany, Gerstner, Thomas V., Yeung, Joanne, Abrams, Elissa M., Mak, Raymond, Erdle, Stephanie C., Soller, Lianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510002/
https://www.ncbi.nlm.nih.gov/pubmed/37780798
http://dx.doi.org/10.1016/j.jacig.2023.100094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510002/
https://www.ncbi.nlm.nih.gov/pubmed/37780798
http://dx.doi.org/10.1016/j.jacig.2023.100094

Ejemplares similares